Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Stem Cells. 2015 May;33(5):1523–1531. doi: 10.1002/stem.1948

Figure 2. Parallel plate flow chamber assay of FTVI-modified and unmodified wild type MSC adherence to TNF-α treated HUVEC.

Figure 2

FTVI modification markedly improved MSC adhesion to HUVEC at 0.5 dynes/cm2. Treatment of HUVEC with anti-E-selectin (anti-CD62E) function-blocking mAb reduced rolling adhesive interactions of FTVI-modified MSC to levels similar to that of unmodified MSC. Similarly, removal of sLex determinants by sialidase treatment of FTVI-modified MSC reduced adhesion to levels equivalent to that of unmodified MSC.